about
Recent advances: Dermatology.Immunosuppressant prograf® (tacrolimus) induces histopathological disorders in the peritubular tissue of rat testes.Atopic dermatitis: from the genes to skin lesions.Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus.Systemic therapy of atopic dermatitis.New approaches to topical therapy.What are the most promising strategies for the therapeutic immunomodulation of allergic diseases?Local therapy for cutaneous and systemic lupus erythematosus: practical and theoretical considerations.Pimecrolimus: a review.The effect of pimecrolimus cream 1% compared with triamcinolone acetonide paste in treatment of atrophic-erosive oral lichen planus.Treatment of erosive oral lichen planus with topical tacrolimus.Macrolactam immunomodulators (tacrolimus and pimecrolimus): new horizons in the topical treatment of inflammatory skin diseases.Novel pharmacological approaches in the treatment of psoriasis.The comparison of efficacy of adcortyl ointment and topical tacrolimus in treatment of erosive oral lichen planus.Netherton syndrome: successful use of topical tacrolimus and pimecrolimus in four siblings.Systemic ciclosporin and tacrolimus in dermatology.Tacrolimus in dermatology-pharmacokinetics, mechanism of action, drug interactions, dosages, and side effects: part I.Pharmacogenetics of Crohn's disease.Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use.Oral lichen planus: update on etiopathogenesis, diagnosis and treatment.Tacrolimus in the treatment of ocular diseases.Systematic review: the role of tacrolimus in the management of Crohn's disease.Topical tacrolimus in anterior segment inflammatory disorders.Successful treatment of severe recalcitrant erosive oral lichen planus with topical tacrolimus.Four cases of facial discoid lupus erythematosus successfully treated with topical pimecrolimus or tacrolimus.An open study of a lotion formulation to improve tolerance of tacrolimus in facial atopic dermatitis.Cutaneous sarcoidosis successfully treated with topical tacrolimus.Tacrolimus enhances irritation in a 5-day human irritancy in vivo model.[Practice experience with topical calcineurin inhibitors].Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus.Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.Topical tacrolimus in granuloma annulare and necrobiosis lipoidica.Localized childhood vulval pemphigoid treated with tacrolimus ointment.Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report.Topical FK506 as immunoprophylaxis after allogeneic penetrating normal-risk keratoplasty: a randomized clinical pilot study.Management of erosive lichen planus with topical tacrolimus and recurrence secondary to metoprolol.Topical treatment of perianal eczema with tacrolimus 0.1%.Generalized pustular psoriasis successfully treated with topical tacrolimus.Toxic absorption of tacrolimus [corrected] in a patient with severe acute graft-versus-host disease.A case of Darier's disease successfully treated with topical tacrolimus.
P2860
Q30850471-AE7DE59D-66C1-4322-BD6B-5E9962B7E29AQ33811601-25A2DD17-D298-4C50-89CD-F0D23FA38F8AQ33884600-E3F8E57C-4929-42E8-8836-70D3C5DEA201Q34076610-F75FC823-A6D3-4444-A886-1B9A64116455Q34106943-B32BA652-60B6-40A9-97D4-1594213BBCD2Q34106948-6C9B2CA8-A8F8-4951-B6C4-3B8F2B5D9B9DQ34190563-DB162267-97EF-4BD0-8F55-4E2E850B16AFQ34227000-780F37A1-8AC3-47A4-BCA9-75A294E02043Q35206755-5E7999B6-E402-48E6-B47A-BC28220C85D5Q35538692-2BD9DBA6-79A0-4DDA-84DE-DAFA4D67C4B4Q35888750-265DBA27-0150-4FFA-9904-C106310F7953Q35922000-58494476-D52B-4D77-A3C2-31F994F09887Q36008673-9E46CF76-B642-4CC9-908E-A0E6352F762AQ36487720-A2E32A39-7D5E-4C9D-9C0A-37E1CFC21A64Q36753715-6C112B32-451C-441A-8490-DCB80FB0AC77Q36986032-1F534D36-BB19-4245-9526-DBC2A6A7B2EFQ37050181-31BD6187-099B-4295-A754-07D701501AE1Q37205946-11AD460A-3E85-4D11-AE07-566A99B52D6BQ37327264-4A4DD145-9854-49E3-9D2D-D32EFACF57C8Q37770241-E53C03AF-4578-4C20-853F-14960626F04AQ37858514-7366CA14-7A90-4D90-9E33-F3C3B625EE39Q37945747-C1B45D14-3916-4EE3-A80E-5E36A918BCDDQ39175604-790B6CA8-8082-4016-8E66-A38B3B636D09Q39356785-E6C5CF5A-2953-4597-8E4A-3BAF4117CD61Q41771409-FFA7A526-ACFA-46E8-94D9-42E5E2EE4E26Q43817762-00EBAE01-7390-4478-B3B2-60D27BB83BE3Q43822661-D47FEFBF-B26B-4D74-BA8B-D1D77D2A32D2Q44041440-35DBA6DD-3964-45E6-B228-00EE65798141Q44420871-BC85B590-F0BB-436A-985B-B03C75DFC826Q44444306-F5F84E7E-08AC-40A4-837D-13AD2A8AE58DQ44841361-A68297B6-6902-4E19-85B5-68FADE6464F4Q44852606-82BCD82F-5AC4-4AB4-BB8E-6352895CDF14Q44876210-FBDA270E-16B7-4125-9EAA-43DA15913CAEQ44902754-FED4F619-626A-4168-9790-3F467FEEAB61Q45250865-67C130B1-05B2-450D-98EA-5001FC919270Q45308071-D3EC9239-C0D3-4D7B-B94C-F84DDB90282FQ45941063-47DF5A75-0AF2-427C-8AB4-0960D53BA0DBQ46401493-E6F36DAB-0877-42EB-BFEF-EE8751742268Q46693833-C5CA2D49-548C-4366-ABC2-263FEAF0C0DFQ46888805-4BC22E74-EA7A-4C45-B24E-56066F645AC3
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Tacrolimus: the drug for the turn of the millennium?
@ast
Tacrolimus: the drug for the turn of the millennium?
@en
type
label
Tacrolimus: the drug for the turn of the millennium?
@ast
Tacrolimus: the drug for the turn of the millennium?
@en
prefLabel
Tacrolimus: the drug for the turn of the millennium?
@ast
Tacrolimus: the drug for the turn of the millennium?
@en
P2093
P1433
P1476
Tacrolimus: the drug for the turn of the millennium?
@en
P2093
P304
P356
10.1001/ARCHDERM.135.5.574
P577
1999-05-01T00:00:00Z